A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults
Clinical trial NCT04883333 · COMPLETED
Trial details
- NCT number
- NCT04883333
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-17
- Primary completion
- 2022-07-18
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.